Pyoderma gangrenosum is a rare infiltrative neutrophilic dermatosis, that is usually characterized by painful ulcers with violaceous, undermined borders on the lower extremities and less commonly by tender nodules or pustules It is often associated with systemic diseases, including inflammatory bowel disease, rheumatoid arthritis, and hematologic disorders The mainstay of treatment is long term immunosuppression often with high dose of corticosteroids, low dose of cyclosporin 3 6 mg/kg/day) or other immunosuppressors We reported the case of a 52 year old woman affected by pyoderma gangrenosum on her right breast She was successfully treated with adalimumab

Pyoderma gangrenosum of the breast treated with adalimumab / Didona, Dario; Paolino, Giovanni; Rasi, Virginia; Cantisani, Carmen; Fania, Luca; Donati, Michele; Viti, Giacomo; Dante Caposiena Caro, Raffaele; Di Biasio, Guido; Moliterni, Elisa; Didona, Biagio. - (2017). ((Intervento presentato al convegno 14th European Academy of Dermatology EADV Spring Symposium tenutosi a Brussels; Belgium.

Pyoderma gangrenosum of the breast treated with adalimumab

Giovanni Paolino
Secondo
;
Carmen Cantisani;Elisa Moliterni
Penultimo
;
2017

Abstract

Pyoderma gangrenosum is a rare infiltrative neutrophilic dermatosis, that is usually characterized by painful ulcers with violaceous, undermined borders on the lower extremities and less commonly by tender nodules or pustules It is often associated with systemic diseases, including inflammatory bowel disease, rheumatoid arthritis, and hematologic disorders The mainstay of treatment is long term immunosuppression often with high dose of corticosteroids, low dose of cyclosporin 3 6 mg/kg/day) or other immunosuppressors We reported the case of a 52 year old woman affected by pyoderma gangrenosum on her right breast She was successfully treated with adalimumab
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1303771
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact